Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Aptanomics

Aptanomics discovers and develops new drugs in major markets of unmet medical need. The Company focuses on well-validated but hard-to-crack therapeutic targets that are involved in signalling pathways that are deregulated in a broad range of cancers. A novel Bcl antagonist and a unique kinase antagonist are currently in development. Aptanomics has made the transition from establishing a robust discovery platform to focusing on the rapid development of its first molecules, which differ from competing products principally because they bind with high specificity to novel, validated sites on intractable targets. The Company's proprietary discovery engine, based on peptide aptamers, delivers a regular flow of new hits against relevant industrial targets. This nourishes its pipeline with a renewable source of product opportunities for in-house development and co-development through partnerships with major pharmaceutical companies. Aptanomics entered into an R&D collaboration with Boehringer Ingelheim in June 2005.


Contact Details:
181-203, avenue Jean Jaurès
Lyon
69007
France
Tel:(33) 4 37 65 55 00
Fax:(33) 4 37 65 06 17
Email:info@aptanomics.com
WWW:

www.aptanomics.com/




Recent Publications by Aptanomics:

Peptide aptamers for small molecule drug discovery.
Peptide aptamers have primarily been used as research tools to manipulate...
6th May, 2009
Aptanomics S.A., Imaxio, Lyon, France. Methods Mol Biol. 2009;535:373-88.
DOI Direct Link
Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
Peptide aptamers are combinatorial proteins that specifically bind...
29th June, 2007
Aptanomics, 181-203, Avenue Jean Jaures, 69007 Lyon, France. Nat Protoc. 2006;1(3):1066-91.
DOI Direct Link
An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity.
Peptide aptamers are combinatorial recognition molecules that consist of a...
5th June, 2007
Aptanomics S.A., 181-203, avenue Jean Jaures, 69007 Lyon, France. Mol Cell Proteomics. 2007 Mar;6(3):451-9. Epub 2006 Dec 4.
DOI Direct Link
Peptide aptamers as guides for small-molecule drug discovery.
Peptide aptamers are combinatorial protein reagents that bind to target...
20th January, 2007
Aptanomics, 181-203 avenue Jean Jaures, 69007 Lyon, France. Drug Discov Today. 2006 Apr;11(7-8):334-41.
DOI Direct Link
A universal transgene silencing method based on RNA interference.
Inducible gene expression systems have contributed significantly to the...
28th July, 2004
Aptanomics and INSERM U412, Ecole Normale Superieure, 46, allee d'Italie, Nucleic Acids Res. 2004 Jul 12;32(12):e102.
DOI Direct Link

View more Aptanomics research publications.

Press Releases on Aptanomics:

BioPortfolio Logo
Aptanomics to validate targets and identify new druggable sites for 1st August, 2005 Aptanomics
Aptanomics to validate targets and identify new druggable sites for Boehringer Ingelheim   Lyon, France, 1st August 2005 - Boehringer
APTANOMICS COMPLETES FUNDING TO DEVELOP NEW DRUG DISCOVERY PLATFORMS 1st October, 2002 Aptanomics
APTANOMICS COMPLETES FUNDING TO DEVELOP NEW DRUG DISCOVERY PLATFORMS BASED ON PEPTIDE APTAMERS Lyon, France, 28 October 2002 Aptanomics announced today
European Biotechnology Crossroads presents international conference 1st January, 1970 Ala
  European Biotechnology Crossroads presents international conference programme 7th European Biotech Crossroads presents international
Aptanomics and Nanosyn collaborate to discover new cancer drugs 1st January, 1970 Aptanomics
Aptanomics and Nanosyn collaborate to discover new cancer drugs Nanosyn and Aptanomics combine their expertise in high quality chemistry and proprietary peptide aptamer

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 2014 times since April 2007, the link to the organisation's website has been followed 581 times

Recent Search Terms used to find this page: aptanomics | Aptanomics | aptanomics | aptanomics | aptanomics | Aptanomics | aptanomics | aptanomics | aptanomics company | aptanomics | .

Search for more companies in Lyon

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aptanomics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.